Immunity to α-Gal: Toward a Single-Antigen Pan-Vaccine To Control Major Infectious Diseases

. 2017 Nov 22 ; 3 (11) : 1140-1142. [epub] 20171110

Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu zprávy

Perzistentní odkaz   https://www.medvik.cz/link/pmid29202015

Zobrazit více v PubMed

WHO. Vector-borne diseases: Fact sheet No. 387 2014; World Health Organization: Geneva, 2017. http://www.who.int/mediacentre/factsheets/fs387/en/ (accessed Oct 9, 2017).

WHO. A global brief on vector-borne diseases; World Health Organization: Geneva, 2014. Available at http://apps.who.int/iris/bitstream/10665/111008/1/WHO_DCO_WHD_2014.1_eng.pdf?ua=1 (accessed Oct 9, 2017).

WHO. Tuberculosis Fact sheet No. 104 2015; World Health Organization: 2017. Available at http://www.who.int/mediacentre/factsheets/fs104/en/ (accessed July 2, 2017).

Yilmaz B.; Portugal S.; Tran T. M.; Gozzelino R.; Ramos S.; Gomes J.; Regalado A.; Cowan P. J.; d’Apice A. J.; Chong A. S.; Doumbo O. K.; Traore B.; Crompton P. D.; Silveira H.; Soares M. P. Gut microbiota elicits a protective immune response against malaria transmission. Cell 2014, 159, 1277–1289. 10.1016/j.cell.2014.10.053. PubMed DOI PMC

Cabezas-Cruz A.; Valdés J. J.; de la Fuente J. Control of vector-borne infectious diseases by human immunity against α-Gal. Expert Rev. Vaccines 2016, 15, 953–955. 10.1080/14760584.2016.1181547. PubMed DOI

Moura A. P. V.; Santos L. C. B.; Brito C. R. N.; Valencia E.; Junqueira C.; Filho A. A. P.; Sant’Anna M. R. V.; Gontijo N. F.; Bartholomeu D. C.; Fujiwara R. T.; Gazzinelli R. T.; McKay C. S.; Sanhueza C. A.; Finn M. G.; Marques A. F. Virus-like Particle Display of the α-Gal Carbohydrate for Vaccination against Leishmania Infection. ACS Cent. Sci. 2017, 3, 1026–1031. 10.1021/acscentsci.7b00311. PubMed DOI PMC

Almeida I. C.; Milani S. R.; Gorin P. A.; Travassos L. R. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies. J. Immunol. 1991, 146, 2394–2400. PubMed

Galili U.; Mandrell R. E.; Hamadeh R. M.; Shohet S. B.; Griffiss J. M. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect. Immun. 1988, 56, 1730–1737. PubMed PMC

Yooseph S.; Kirkness E. F.; Tran T. M.; Harkins D. M.; Jones M. B.; Torralba M. G.; O’Connell E.; Nutman T. B.; Doumbo S.; Doumbo O. K.; Traore B.; Crompton P. D.; Nelson K. E. Stool microbiota composition is associated with the prospective risk of Plasmodium falciparum infection. BMC Genomics 2015, 16, 631.10.1186/s12864-015-1819-3. PubMed DOI PMC

Cabezas-Cruz A.; Mateos-Hernández L.; Alberdi P.; Villar M.; Riveau G.; Hermann E.; Schacht A. M.; Khalife J.; Correia-Neves M.; Gortazar C.; de la Fuente J. Effect of blood type on anti-α-Gal immunity and the incidence of infectious diseases. Exp. Mol. Med. 2017, 49, e301.10.1038/emm.2016.164. PubMed DOI PMC

Zamze S. E.; Ashford D. A.; Wooten E. W.; Rademacher T. W.; Dwek R. A. Structural characterization of the asparagine-linked oligosaccharides from Trypanosoma brucei type II and type III variant surface glycoproteins. J. Biol. Chem. 1991, 266, 20244–20261. PubMed

Couto A. S.; Gonçalves M. F.; Colli W.; de Lederkremer R. M. The N-linked carbohydrate chain of the 85-kilodalton glycoprotein from Trypanosoma cruzi trypomastigotes contains sialyl, fucosyl and galactosyl (alpha 1–3)galactose units. Mol. Biochem. Parasitol. 1990, 39, 101–7. 10.1016/0166-6851(90)90012-B. PubMed DOI

Najít záznam

Citační ukazatele

Možnosti archivace